INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, has announced it has entered into a know-how collaboration agreement with Mayo Clinic. The collaboration seeks to accelerate the development and commercialization of INBRAIN’s precision BCI-Tx for patients with unmet needs in neurological-related disorders.
